 insulin-sulfonylurea therapy treatment NIDDM past years interest combination insulin sulfonylurea search effective treatments non-insulin-dependent diabetes NIDDM patients oral hypoglycemic agents several studies beneficial effects therapy NIDDM patients average effect small half patients several problems previous studies small sample size selection patients simultaneous use several end points First residual beta-cell function prerequisite beneficial effect combination therapy studies improved glycemic control sulfonylurea therapy patients insulin-dependent diabetes mellitus Inclusion patients impaired beta-cell function effect combination therapy Second studies glycemic control end point Nevertheless insulin dose hypoglycemia sulfonylurea comparison treatments insulin dose sulfonylurea insulin dose sulfonylurea patient likely combination therapy obese NIDDM short period beta-cell function patient insulin-sulfonylurea therapy basal insulin secretion effective suppression hepatic glucose production plasma glucose side effects frequent mild hypoglycemic reactions